IT & Data Management
Heraeus expands cancer therapy API capacity
Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients (Pt HPAPIs) with an additional production line built at the company’s headquarters in Hanau, Germany.
Heraeus is the leading...
News
India to grow strongly in 2020 as CPhI & P-MEC India opens
CPhI & P-MEC India – organised by Informa Markets – is set to open its doors to more than 43,000 attendees from 120 countries and 1,500 exhibitors, as new analysis shows a massive improvement in India’s global reputation. The...
IT & Data Management
Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making
Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growth.
Debiopharm is...
News
CSafe Global expands cold chain offerings in China by opening new service center at Shanghai Pudong International Airport
CSafe has expanded its cold chain service offerings in China by opening a new service center at the Shanghai Pudong International Airport (PVG), serving a higher volume of inbound and outbound traffic of the innovative CSafe RAP and CSafe...
News
TraceLink Appoints Merck KGaA Thought Leader to Drive Strategy for Deployment of Advanced Analytics across Life Sciences Industry
TraceLink Inc., the worlds largest integrated digital supply network providing real-time information sharing for better patient outcomes, announced that Bharath Sundararaman has joined the Company as General Manager of its Intelligent Supply Network business area.
Sundararaman comes to TraceLink after...
Drug Research
Dicerna, Novo Nordisk sign RNAi deal for liver-related cardio-metabolic diseases
US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs for liver-related cardio-metabolic diseases.
In this regard, the companies will make use of GalXC, an RNA interference (RNAi) technology platform...
IT & Data Management
Enhanced Cell Line Productivity Technology to be Introduced by Catalent Biologics at PEGS Europe
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced that Greg Bleck, Ph.D., Global Head of R&D, Catalent Biologics will present at the upcoming annual...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read